Go to AAD Home
Donate For Public and Patients Store Search
Go to AAD Home
Main menu
Membership
Meetings & Education
Practice management
Clinical & quality
Publications & apps
Career development
Advocacy
Back
Account
Pay dues
Member ID
Join the AAD
Member benefits
Find a member
AAD election
AAD governance
Support AAD
AAD Help Center
2025 Annual Meeting
2025 Innovation Academy
Academy meetings archive
Professional education
Claim CME & view transcript
Upcoming events
Residents & medical students
Patient education materials
DataDerm
Coding Resource Center
MIPS & fee schedule
Teledermatology
EHR & health tech
Insurance & drugs
Compliance & practice scope
Managing your practice
Clinical guidelines
Quality measures
DataDerm
Quality & patient safety
Clinical Community
Clinical care resources
Position statements
JAAD
JAAD International
JAAD Case Reports
Dermatology World
DermWorld Insights & Inquiries
Derm Coding Consult
DermWorld Meeting News
Impact Report
Other publications
Academy Apps
Job board
Join or sell a practice
Burnout & wellness
Career launch
Diversity
Awards, grants, and scholarships
Leadership Institute
Volunteer opportunities
Ethics & professionalism
Take action
Advocacy priorities
State advocacy resources
Legislative Conference
Position statements
Promote the specialty
Key Contacts
Patient advocate resources
SkinPAC
Advocacy Update
Welcome!

AADA statement on FDA Notice for Environmental Impact Statement for certain sunscreen drug products

ROSEMONT, Ill. (May 14, 2021) — The American Academy of Dermatology Association (AADA) and its members are committed to the health and safety of the public including the prevention of skin cancer.

The U.S. Food and Drug Administration (FDA) recently published a notice on the study of environmental impacts associated with oxybenzone and octinoxate in sunscreen products. The Academy appreciates the efforts of the agency to thoroughly examine all relevant science before issuing a final sunscreen order on these ingredients.

Skin cancer is the most common cancer in the U.S., and unprotected exposure to the sun’s harmful ultraviolet rays is a major risk factor. The AADA continues to focus on encouraging members of the public to protect themselves by seeking shade, wearing protective clothing — including a lightweight and long-sleeved shirt, pants, a wide-brimmed hat and sunglasses — and applying a broad-spectrum sunscreen with an SPF of 30 or higher to all exposed skin.

The AADA remains committed to supporting dermatologists in offering quality care and information to patients. We continue to track the FDA’s sunscreen actions and will provide updates and resources to our members.

# # #

Contact

Kamilah Howard, (202) 615-5920, khoward@aad.org

Nicole Dobkin, (847) 240-1746, ndobkin@aad.org

About the AAD Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 20,000 physicians worldwide, the AAD is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow the AAD on Facebook (American Academy of Dermatology), Twitter (@AADskin), Instagram (@AADskin1), or YouTube (AcademyofDermatology).